Cambridge Investment Research Advisors’s Houlihan Lokey HLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$305K Buy
2,276
+81
+4% +$12K ﹤0.01% 3432
2026
Q1
$315K Sell
2,195
-108
-5% -$17.8K ﹤0.01% 3236
2025
Q4
$401K Buy
2,303
+15
+0.7% +$2.75K ﹤0.01% 2931
2025
Q3
$470K Sell
2,288
-1,336
-37% -$262K ﹤0.01% 2735
2025
Q2
$652K Buy
3,624
+11
+0.3% +$1.85K ﹤0.01% 2300
2025
Q1
$583K Buy
3,613
+2,036
+129% +$350K ﹤0.01% 2286
2024
Q4
$274K Buy
+1,577
New +$278K ﹤0.01% 2905

Other funds holding HLI

Cambridge Investment Research Advisors's HLI Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Houlihan Lokey (HLI) stake by 3.7% in Q2 2026, buying an estimated $12K and bringing the position to 2,276 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #3432.

Cambridge Investment Research Advisors first reported a position in HLI in Q4 2024 and has held it in 7 quarters since. The position peaked at $652K in Q2 2025. 515 funds tracked by Wall St. Rank hold HLI as of Q2 2026.

  • Cambridge Investment Research Advisors held 2,276 shares of Houlihan Lokey worth $305K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 81 Houlihan Lokey shares in Q2 2026, an estimated $12K.
  • Houlihan Lokey made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3432 holding.
  • Cambridge Investment Research Advisors first reported a position in Houlihan Lokey in Q4 2024 and has held it in 7 quarters since.
  • Cambridge Investment Research Advisors's Houlihan Lokey position peaked at $652K in Q2 2025.
  • 515 funds tracked by Wall St. Rank held Houlihan Lokey as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.